Phocas Financial Corp’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-130,705
| Closed | -$2.49M | – | 330 |
|
|
2022
Q3 | $2.49M | Buy |
130,705
+2,756
| +2% | +$52.6K | 0.39% | 106 |
|
|
2022
Q2 | $2.33M | Sell |
127,949
-1,486
| -1% | -$27K | 0.35% | 111 |
|
|
2022
Q1 | $3.26M | Sell |
129,435
-2,666
| -2% | -$67.2K | 0.41% | 101 |
|
|
2021
Q4 | $3.65M | Sell |
132,101
-3,166
| -2% | -$87.4K | 0.46% | 89 |
|
|
2021
Q3 | $4.37M | Buy |
135,267
+27,568
| +26% | +$890K | 0.55% | 78 |
|
|
2021
Q2 | $3.29M | Buy |
+107,699
| New | +$3.29M | 0.41% | 101 |
|
|
2019
Q1 | – | Sell |
-120
| Closed | -$3K | – | 278 |
|
|
2018
Q4 | $3K | Buy |
+120
| New | +$3K | ﹤0.01% | 320 |
|